- Home
- EDBL vs KTTA Comparison
EDBL vs KTTA Comparison
Compare EDBL & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- KTTA
- Stock Information
- Founded
- EDBL 2020
- KTTA 2020
- Country
- EDBL United States
- KTTA United States
- Employees
- EDBL N/A
- KTTA N/A
- Industry
- EDBL Farming/Seeds/Milling
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- KTTA Health Care
- Exchange
- EDBL Nasdaq
- KTTA Nasdaq
- Market Cap
- EDBL 5.4M
- KTTA 5.7M
- IPO Year
- EDBL 2022
- KTTA 2021
- Fundamental
- Price
- EDBL $1.64
- KTTA $0.74
- Analyst Decision
- EDBL
- KTTA
- Analyst Count
- EDBL 0
- KTTA 0
- Target Price
- EDBL N/A
- KTTA N/A
- AVG Volume (30 Days)
- EDBL 510.7K
- KTTA 79.1K
- Earning Date
- EDBL 11-14-2025
- KTTA 11-14-2025
- Dividend Yield
- EDBL N/A
- KTTA N/A
- EPS Growth
- EDBL N/A
- KTTA N/A
- EPS
- EDBL N/A
- KTTA N/A
- Revenue
- EDBL $12,320,000.00
- KTTA N/A
- Revenue This Year
- EDBL $29.56
- KTTA N/A
- Revenue Next Year
- EDBL $20.00
- KTTA N/A
- P/E Ratio
- EDBL N/A
- KTTA N/A
- Revenue Growth
- EDBL N/A
- KTTA N/A
- 52 Week Low
- EDBL $1.52
- KTTA $0.65
- 52 Week High
- EDBL $13.50
- KTTA $4.35
- Technical
- Relative Strength Index (RSI)
- EDBL 42.64
- KTTA 46.19
- Support Level
- EDBL $1.58
- KTTA $0.69
- Resistance Level
- EDBL $2.78
- KTTA $0.78
- Average True Range (ATR)
- EDBL 0.19
- KTTA 0.04
- MACD
- EDBL -0.02
- KTTA -0.00
- Stochastic Oscillator
- EDBL 12.70
- KTTA 33.17
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).